Quest Diagnostics' Zika Assay Gets FDA Emergency Use Authorization | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics said late on Thursday that it has received US Food and Drug Administration Emergency Use Authorization for the Zika Virus RNA Qualitative Real-Time RT-PCR test.

The assay, developed by the reference laboratory business of Quest's Focus Diagnostics subsidiary, is intended for the qualitative detection of Zika virus RNA in human serum specimens from certain individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.